|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 155 TWD | +1.97% |
|
+1.31% | +1.97% |
Syngen Biotech Co.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 444.1 million compared to TWD 378.68 million a year ago. Net income was TWD 72.92 million compared to TWD 65.33 million a year ago.
Basic earnings per share from continuing operations was TWD 2.69 compared to TWD 2.41 a year ago. Diluted earnings per share from continuing operations was TWD 2.69 compared to TWD 2.41 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.97% | 130M | |
| +38.59% | 727B | |
| -7.89% | 347B | |
| +15.66% | 319B | |
| +0.24% | 274B | |
| +13.47% | 238B | |
| +7.35% | 204B | |
| -6.42% | 203B | |
| +4.23% | 161B | |
| -1.70% | 160B |
SYNGEN BIOTECH CO.,LTD. 
